National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Chronic Myeloproliferative Disorders Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/01/2008



General Information About Chronic Myeloproliferative Disorders






Chronic Myelogenous Leukemia







Polycythemia Vera






Chronic Idiopathic Myelofibrosis






Essential Thrombocythemia






Chronic Neutrophilic Leukemia






Chronic Eosinophilic Leukemia






Stages of Chronic Myeloproliferative Disorders






Treatment Option Overview






Treatment Options for Chronic Myeloproliferative Disorders






To Learn More About Chronic Myeloproliferative Disorders






Get More Information From NCI






Changes to This Summary (08/01/2008)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Polycythemia Vera

Key Points for This Section


Polycythemia vera is a disease in which too many red blood cells are made in the bone marrow.

In polycythemia vera, the blood becomes thickened with too many red blood cells. The number of white blood cells and platelets may also increase. These extra blood cells may collect in the spleen and cause it to swell. The increased number of red blood cells or platelets in the blood can cause bleeding problems and make clots form in blood vessels. This can cause serious health problems such as stroke or heart attack. In patients older than 65 years, the risk of stroke and heart attack is higher, and polycythemia vera is more likely to become acute myeloid leukemia or chronic idiopathic myelofibrosis.

Possible signs of polycythemia vera include headaches and a feeling of fullness below the ribs on the left side.

Polycythemia vera often does not cause early symptoms. It is sometimes found during a routine blood test. Symptoms may occur as the number of blood cells increases. Other conditions may cause the same symptoms. A doctor should be consulted if any of the following problems occur:

  • A feeling of pressure or fullness below the ribs on the left side.
  • Headaches.
  • Double vision or seeing dark or blind spots that come and go.
  • Itching all over the body, especially after being in warm or hot water.
  • Reddened face that looks like a blush or sunburn.
  • Weakness.
  • Dizziness.
  • Weight loss for no known reason.

Special blood tests are used to diagnose polycythemia vera.

In addition to a complete blood count, other special blood tests are used to diagnose polycythemia vera. These tests include the following:

  • Arterial blood gas (ABG) test: A test in which a sample of blood is taken from an artery to measure the amount of oxygen and carbon dioxide in the blood and the pH (acidity) of the blood.
  • Serum erythropoietin test: A test in which a sample of blood is checked for the level of erythropoietin (a hormone that stimulates new red blood cells to be made).
  • Leukocyte alkaline phosphatase (LAP) test: A test in which a sample of blood is checked to measure the amount of alkaline phosphatase (an enzyme) in leukocytes (white blood cells).

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov